Genetic Testing Services Market Report 2026

Genetic Testing Services Market Overview

• Genetic Testing Services market size has reached to $21.36 billion in 2025 • Expected to grow to $34.09 billion in 2030 at a compound annual growth rate (CAGR) of 9.5% • Growth Driver: Increasing Prevalence Of Genetic Disorders Fuels Growth In Genetic Testing Services Market • Market Trend: Advancements In Cancer Screening Tests By Leading Genetic Testing Companies • North America was the largest region in 2025.

What Is Covered Under Genetic Testing Services Market?

Genetic testing services refers to analyzing an individual's DNA to identify variations or mutations that could indicate disease risk, ancestry, or other genetic traits. These services typically offer insights into potential health conditions, ancestry, and personalized recommendations based on genetic predispositions, often facilitating informed medical decisions and lifestyle choices. The main types of genetic testing services are predictive testing, carrier testing, prenatal testing, newborn screening, and others. Predictive testing refers to a medical or genetic testing process used to determine an individual's likelihood of developing a certain condition or disease in the future. The diseases include cancer disease, metabolic disease, cardiovascular disease, and others and are used by various end users, such as diagnostic laboratories, hospitals and clinics, academic institutes and research centers, and others.

What Is The Genetic Testing Services Market Growth Forecast?

The genetic testing services market size is expected to see strong growth in the next few years. It will grow to $34.09 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to integration of genomics into routine care, demand for personalized health insights, expansion of digital health platforms, regulatory clarity for testing services, growth of preventive medicine. Major trends in the forecast period include growth of direct-to-consumer genetic testing services, increasing demand for disease risk assessment services, expansion of prenatal and newborn genetic services, rising adoption of ancestry and genealogy testing, increased use of genetic counseling services.

Global Genetic Testing Services Market Segmentation

1) By Type: Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, Other Types 2) By Disease: Cancer Disease, Metabolic Disease, Cardiovascular Disease, Other Diseases 3) By End User: Diagnostic Laboratories, Hospitals And Clinics, Academic Institutes And Research Centers, Other End Users Subsegments: 1) By Predictive Testing: Cancer Predisposition Testing, Heart Disease Risk Testing, Neurological Disorder Risk Testing, Other Predictive Tests 2) By Carrier Testing: Carrier Screening For Single-Gene Disorders, Carrier Screening For Multifactorial Conditions, Carrier Screening For Inherited Genetic Conditions, Other Carrier Tests 3) By Prenatal Testing: Non-Invasive Prenatal Testing (NIPT), Amniocentesis, Chorionic Villus Sampling (CVS), Ultrasound-Combined Genetic Testing, Other Prenatal Tests 4) By Newborn Screening: Metabolic Disorder Screening, Genetic Disorder Screening, Hearing Loss Screening, Endocrine Disorder Screening, Other Newborn Screening Tests 5) By Other Types: Pharmacogenetic Testing, Forensic Genetic Testing, Ancestry And Genetic Genealogy Testing, Paternity Testing, Other Specialized Genetic Tests

What Is The Driver Of The Genetic Testing Services Market?

The increasing prevalence of genetic disorders is expected to propel the growth of the genetic testing services market going forward. Genetic disorders are conditions caused by abnormalities in an individual's DNA, leading to physical or developmental abnormalities. The increasing prevalence of genetic disorders can be attributed to factors such as increased awareness, improved diagnostic techniques, expanded genetic screening, and the rising trend of consanguineous marriages in some populations. Genetic testing services are increasingly utilized in the diagnosis, prognosis, and treatment decision-making for individuals with genetic disorders, enabling personalized medical care and family planning strategies based on an individual's genetic makeup. For instance, in February 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, congenital diseases caused an estimated 240,000 baby deaths globally within 28 days of birth each year. Moreover, according to the Centers for Disease Control and Prevention, a US-based government agency, about 6,000 babies are born with Down syndrome in the United States each year, which is about 1 in every 700 babies. Therefore, the increasing prevalence of genetic disorders is driving the genetic testing services industry.

Key Players In The Global Genetic Testing Services Market

Major companies operating in the genetic testing services market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, SGS SA, Agilent Technologies, Hologic Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, NeoGenomics Laboratories Inc, 23andMe Holding Co, Berry Genomics Co. Ltd, Pacific Biosciences of California Inc, Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Blueprint Genetics Oy, Igenomix, Veritas Genetics

Global Genetic Testing Services Market Trends and Insights

Major companies operating in the genetic testing services market are focusing on developing advanced technological solutions, such as cancer screening tests, to enhance accuracy, expand testing capabilities, and improve overall patient outcomes. Cancer screening tests refer to routine, periodic tests conducted on individuals without symptoms to detect signs of cancer early. These tests aim to identify cancer or precancerous conditions before symptoms manifest, making treatment more effective. For instance, in May 2025, Guardant Health, a United States based provider of precision oncology diagnostics, including blood based liquid biopsies and genetic profiling, launched the Guardant Hereditary Cancer test to expand its genetic testing services into hereditary cancer risk assessment and thereby enhance its screening and prevention platform in oncology care. Guardant Health’s test provides a blood-based 82-gene hereditary cancer panel that can be paired with Guardant360 using the same sample, delivering quick results within 2–3 weeks for streamlined inherited cancer risk detection.

What Are Latest Mergers And Acquisitions In The Genetic Testing Services Market?

In February 2025, Tempus, a US-based provider of precision medicine solutions, artificial intelligence-driven clinical insights, and oncology-focused genetic testing services, acquired Ambry Genetics for an undisclosed amount. With this acquisition, Tempus aims to expand its genetic testing capabilities and integrate Ambry’s hereditary disease testing services into its precision medicine platform, enhancing both technological capability and market presence in clinical genetic diagnostics. Ambry Genetics is a US-based provider of hereditary cancer, cardiovascular, pediatric, and rare disease genetic testing services, offering comprehensive diagnostic solutions for clinical and research applications.

Regional Outlook

North America was the largest region in the genetic testing services market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Genetic Testing Services Market?

The genetic testing services market consists of revenues earned by entities by providing services such as newborn screening, diagnostic testing, carrier testing, prenatal testing, preimplantation testing, predictive and presymptomatic testing, ancestry testing, nutrigenomics testing, and forensic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Genetic Testing Services Market Report 2026?

The genetic testing services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the genetic testing services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.